Kampala, Uganda | THE INDEPENDENT | Researchers will in December enroll the first participants in a clinical trial in which they are testing the effectiveness of a new HIV drug, Lenacapavir in protecting people against the virus. This study will be conducted in four districts of Mityana, Masaka, Hoima and Kalangala …
Read More »
Masaka, Uganda | THE INDEPENDENT | Researchers are studying the effectiveness of a daily Pre-Exposure Prophylaxis (PrEP) drug Descovy in their HIV vaccine study that was launched recently in Masaka district. Dr Eugene Ruzagira, a member of the team of researchers told a news conference organized by the Health Journalists Network …
Read More »
Kampala, Uganda | THE INDEPENDENT | A new HIV Pre-exposure Prophylaxis (PrEP) study is underway to establish whether a six months-long injectable drug, Lenacapavir (LEN), and oral drug Descovy can protect HIV negative women and girls from acquiring the virus. The two-part study is being done by a team of researchers …
Read More »
The Independent Uganda: You get the Truth we Pay the Price